Skip to main content
Reimbursement strategy

Cost-effective market access strategy for medical technologies in Europe

A holistic approach to reimbursement strategies trusted by global market leaders and SMEs

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

2024 Norwegian DRG system released

In December 2023, the Norwegian Directorate of Health published a final version of the DRG system (Innsatsstyrt finansiering, ISF) for 2024. ISF is activity-based funding to the regional health authorities (Regionale Helseforetak, RHF) through the national budget. In general, no significant changes were introduced in 2024. The financing of the RHFs is mainly two-fold and consists of a basic grant and activity-based funding (ISF). For 2024, the ISF share for somatic specialist care is about 40%, and the basic grant is about 60% (no changes from 2023).

The Norwegian DRG system (ISF) consists of three parts:

  • Diagnosis-related groups (DRG);
  • Special Service Groups (Særtjenestegrupper, STG), which cover specialist health services that take place in other than traditional inpatient and outpatient settings, are extended over a long period of time so that the patient himself is more responsible for the administration of the treatment (e.g., patient-administered peritoneal dialysis or hemodialysis, telemedicine);
  • Service Course Groups (Tjenesteforløps grupper, TFG), which refer to "bundled payments," so it is an aggregated level above DRG and STG, providing financing of a patient treatment course with several stays and activities (e.g., dialysis treatment, insertion of hip prostheses).

No new DRGs will be added in 2024. One new STG for light treatment and five new TFGs (without tariffs, to be used for data collection) concerning maternity care pathways will be introduced. Some examples of new TFGs are provided below:

  • PT11 Pregnancy and childbirth pathway with complicating factors;
  • PT14 Pregnancy and childbirth pathway with resource-intensive interventions without complicating factors.

In 2024, to obtain DRG/STG/TFG tariffs for somatic care, cost-weights must be multiplied on a base tariff of 52,248 NOK.

See more information in Norwegian here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.